Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom
Open Access
- 15 September 2022
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-9
Abstract
Background: Increased total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and decreased high-density lipoprotein cholesterol (HDL-C) concentrations, are established risk factors for cardiovascular morbidity and mortality; but their impact on the risk of advanced chronic kidney disease (CKD) is unclear. This study evaluates the association between the different lipid profiles and the onset of advanced CKD using a general population sample. Methods: This observational study used records of 911,360 individuals from the English Clinical Practice Research Datalink (from 2000 to 2014), linked to coded hospital discharges and mortality registrations. Cox models were used to examine the independent association between the equal quarters of TC, TG, LDL-C, and HDL-C and the risk of advanced CKD, after adjustment for sex and age, and potential effect mediators. Results: During a median follow-up of 7.5 years, 11,825 individuals developed CKD stages 4–5. After adjustment for sex and age, the hazard ratios (HRs) and confidence intervals (CIs) for CKD stages 4–5 comparing the 4th vs. 1st quarters of TG and 1st vs. 4th quarters of HDL-C were 2.69 (95% CI, 2.49–2.90) and 2.61 (95% CI, 2.42–2.80), respectively. Additional adjustment for potential effect mediators reduced the HRs to 1.28 (95% CI, 1.15–1.43), and 1.27 (95% CI, 1.14–1.41), respectively. There was no evidence of fully adjusted associations with CKD stages 4–5 for levels of either TC or LDL-C. Conclusions: Elevated TG and reduced HDL-C levels are independently associated with the onset of advanced CKD. Future studies, such as in basic science and randomized trials, are needed to understand whether associations between TG and HDL-C and the development of CKD are causal.Keywords
This publication has 33 references indexed in Scilit:
- Metabolic Syndrome and Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- High-density lipoproteins, inflammation and oxidative stressClinical Science, 2008
- Predictors of new-onset decline in kidney function in a general middle-european populationNephrology Dialysis Transplantation, 2007
- Predictors of New-Onset Kidney Disease in a Community-Based PopulationJAMA, 2004
- Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuriaKidney International, 2002
- Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities StudyKidney International, 2000
- Estrogen effects on triglyceride metabolism in analbuminemic ratsKidney International, 2000